Second Quarter 2025 Results Key Financial Results Revenue: US$483.4m (up 4.3% from ...

First Quarter 2026 Results Key Financial Results Revenue: US$304.9m (up 15% from ...

Q2 2025 Earnings Call Transcript August 1, 2025 Fortis Inc. beats earnings expectations. Reported EPS is $0.558, expectations ...

Q1 2026 Earnings Call Transcript August 1, 2025 RBC Bearings Incorporated beats earnings expectations. Reported EPS is $2.84, ...

Operator: Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today.

Key Points - Non-GAAP earnings per share were $0.74 for the fiscal second quarter ended June 30, 2025, beating estimates by $0.03 (non-GAAP). Revenue reached $1,140.4 million for the fiscal second ...

Key Points Earnings per share (Non-GAAP) were $0.94 in Q2 2025 beating the analyst estimate by 9.3% (non-GAAP) and the company exceeded its non-GAAP EPS outlook by $0.08. Net sales (GAAP) reached ...

But there is a non-statistical basis for concern: an ominous parallel with the financial environment that prevailed in the weeks leading up to the October 1987 stock-market crash. On that day - Black ...

Praxis Precision Medicine PRAX -4.09% Get Free Report will release its quarterly earnings report on Monday, 2025-08-04. Here's a brief overview for investors ahead of the announcement. Analysts ...

Management reaffirmed 2025 operating earnings per share guidance of $3.28 to $3.52, with a midpoint of $3.40. Ridge stated, "I'm highly confident in our ability to deliver on our financial plan, ...

Analysts are estimating that Castle Biosciences will report an earnings per share (EPS) of $-0.50. Investors in Castle Biosciences are eagerly awaiting the company's announcement, hoping for news of ...